{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:24:47Z","timestamp":1772166287542,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to compare the outcomes of patients with ground-grass opacity (GGO)-dominant non-small cell lung cancer (NSCLC) who were treated with carbon ion radiotherapy (CIRT) versus segmentectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective review of medical records was conducted. The study included 123 cases of clinical stage 0\/IA peripheral NSCLC treated with single-fraction CIRT from 2003 to 2012, 14 of which were determined to be GGO-dominant and were assigned to CIRT group. As a control, 48 consecutive patients who underwent segmentectomy for peripheral GGO-dominant clinical stage IA NSCLC were assigned to segmentectomy group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The patients in CIRT group, compared with segmentectomy group, were significantly older (75\u2009\u00b1\u20097.2 vs. 65\u2009\u00b1\u20098.2\u00a0years,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.000660), more likely to be male (13\/14 vs. 22\/48,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.00179), and had a lower forced vital capacity (91\u2009\u00b1\u200919% vs. 110\u2009\u00b1\u200913%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0173). There was a significant difference in the 5-years overall survival rate (86% vs. 96%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.000860), but not in the 5-years disease-specific survival rate (93% vs. 98%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.368).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Compared with segmentectomy, CIRT may be an alternative option for patients with early GGO-dominant NSCLC who are poor candidates for, or who refuse, surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-023-02387-1","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T02:02:12Z","timestamp":1702864932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of carbon ion radiotherapy compared with segmentectomy for ground glass opacity-dominant early-stage lung cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Teruaki","family":"Mizobuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"2387_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2387_CR2","unstructured":"NCCN clinical practice guidelines in oncology, non-small cell lung cancer. Version 3.2020."},{"key":"2387_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jtho.2018.10.002","volume":"14","author":"J Okami","year":"2019","unstructured":"Okami J, Shintani Y, Okumura M, Ito H, Ohtsuka T, Toyooka S, et al. Japanese Joint Committee of Lung Cancer Registry. Demographics, safety and quality, and prognostic information in both the seventh and eighth editions of the TNM classification in 18,973 surgical cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010. J Thorac Oncol. 2019;14:212\u201322.","journal-title":"J Thorac Oncol"},{"key":"2387_CR4","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1097\/JTO.0b013e318219aae2","volume":"6","author":"N Sawabata","year":"2011","unstructured":"Sawabata N, Miyaoka E, Asamura H, Nakanishi Y, Eguchi K, Mori M, et al. Japanese Joint Committee for Lung Cancer Registration. Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol. 2011;6:1229\u201335.","journal-title":"J Thorac Oncol"},{"key":"2387_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/JTO.0b013e31815e8577","volume":"3","author":"H Asamura","year":"2008","unstructured":"Asamura H, Goya T, Koshiishi Y, Sohara Y, Eguchi K, Mori M, et al. A Japanese lung cancer registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol. 2008;3:46\u201352.","journal-title":"J Thorac Oncol"},{"key":"2387_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0022-5223(20)31797-9","volume":"39","author":"WG Cahan","year":"1960","unstructured":"Cahan WG. Radical lobectomy. J Thorac Cardiovasc Surg. 1960;39:555\u201372.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2387_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0003-4975(95)00537-U","volume":"60","author":"RJ Ginsberg","year":"1995","unstructured":"Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer: Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615\u201322.","journal-title":"Ann Thorac Surg"},{"key":"2387_CR8","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1097\/JTO.0b013e3181560a68","volume":"2","author":"T Miyamoto","year":"2007","unstructured":"Miyamoto T, Baba M, Sugane T, Nakajima M, Yashiro T, Kagei K, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol. 2007;2:916\u201326.","journal-title":"J Thorac Oncol"},{"key":"2387_CR9","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/S1470-2045(14)70412-7","volume":"16","author":"T Kamada","year":"2015","unstructured":"Kamada T, Tsujii H, Blakely EA, Debus J, De Neve W, Durante M, et al. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience. Lancet Oncol. 2015;16:e93-100.","journal-title":"Lancet Oncol"},{"key":"2387_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0167-8140(02)00367-5","volume":"66","author":"T Miyamoto","year":"2003","unstructured":"Miyamoto T, Yamamoto N, Nishimura H, Koto M, Tsujii H, Mizoe JE, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol. 2003;66:127\u201340.","journal-title":"Radiother Oncol"},{"key":"2387_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0169-5002(03)00243-5","volume":"42","author":"N Yamamoto","year":"2003","unstructured":"Yamamoto N, Miyamoto T, Nishimura H, Koto M, Tsujii H, Ohwada H, et al. Preoperative carbon ion radiotherapy for non-small cell lung cancer with chest wall invasion\u2013pathological findings concerning tumor response and radiation induced lung injury in the resected organs. Lung Cancer. 2003;42:87\u201395.","journal-title":"Lung Cancer"},{"key":"2387_CR12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0360-3016(02)04495-4","volume":"55","author":"H Nishimura","year":"2003","unstructured":"Nishimura H, Miyamoto T, Yamamoto N, Koto M, Sugimura K, Tsujii H. Radiographic pulmonary and pleural changes after carbon ion irradiation. Int J Radiat Oncol Biol Phys. 2003;55:861\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2387_CR13","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1378\/chest.122.6.1925","volume":"122","author":"K Kadono","year":"2002","unstructured":"Kadono K, Homma T, Kamahara K, Nakayama M, Satoh H, Sekizawa K, et al. Effect of heavy-ion radiotherapy on pulmonary function in stage I non-small cell lung cancer patients. Chest. 2002;122:1925\u201332.","journal-title":"Chest"},{"key":"2387_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.radonc.2004.02.007","volume":"71","author":"M Koto","year":"2004","unstructured":"Koto M, Miyamoto T, Yamamoto N, Nishimura H, Yamada S, Tsujii H. Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol. 2004;71:147\u201356.","journal-title":"Radiother Oncol"},{"key":"2387_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.ijrobp.2006.10.006","volume":"67","author":"T Miyamoto","year":"2007","unstructured":"Miyamoto T, Baba M, Yamamoto N, Koto M, Sugawara T, Yashiro T, et al. Working Group for Lung Cancer. Curative treatment of stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys. 2007;67:750\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2387_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lungcan.2008.07.007","volume":"64","author":"T Sugane","year":"2009","unstructured":"Sugane T, Baba M, Imai R, Nakajima M, Yamamoto N, Miyamoto T, et al. Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer. Lung Cancer. 2009;64:45\u201350.","journal-title":"Lung Cancer"},{"key":"2387_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jtho.2016.12.012","volume":"12","author":"N Yamamoto","year":"2017","unstructured":"Yamamoto N, Miyamoto T, Nakajima M, Karube M, Hayashi K, Tsuji H, et al. A dose escalation clinical trial of single-fraction carbon ion radiotherapy for peripheral stage I non-small cell lung cancer. J Thorac Oncol. 2017;12:673\u201380.","journal-title":"J Thorac Oncol"},{"key":"2387_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/JTO.0b013e31821038ab","volume":"6","author":"K Suzuki","year":"2011","unstructured":"Suzuki K, Koike T, Asakawa T, Kusumoto M, Asamura H, Nagai K, Tada H, et al. Japan Lung Cancer Surgical Study Group (JCOG LCSSG). A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol. 2011;6:751\u20136.","journal-title":"J Thorac Oncol"},{"key":"2387_CR19","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","volume":"399","author":"H Saji","year":"2022","unstructured":"Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, et al. West Japan Oncology Group and Japan Clinical Oncology Group. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomized, controlled, non-inferiority trial. Lancet. 2022;399:1607\u201317.","journal-title":"Lancet"},{"key":"2387_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/icvts\/ivv124","volume":"21","author":"K Suzuki","year":"2015","unstructured":"Suzuki K, Watanabe S, Mizusawa J, Moriya Y, Yoshino I, Tsuboi M, et al. Japan Lung Cancer Surgical Study Group (JCOG LCSSG). Predictors of non-neoplastic lesions in lung tumours showing ground-glass opacity on thin-section computed tomography based on a multi-institutional prospective study. Interact Cardiovasc Thorac Surg. 2015;21:218\u201323.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2387_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11748-016-0741-1","volume":"65","author":"K Aokage","year":"2017","unstructured":"Aokage K, Saji H, Suzuki K, Mizutani T, Katayama H, Shibata T, et al. Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211). Gen Thorac Cardiovasc Surg. 2017;65:267\u201372.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2387_CR22","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2387_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/JTO.0b013e3181d35627","volume":"5","author":"T Nakajima","year":"2010","unstructured":"Nakajima T, Yasufuku K, Nakajima M, Baba M, Yoshikawa K, Kamada T, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with non-small cell lung cancer in non-operable patients pursuing radiotherapy as a primary treatment. J Thorac Oncol. 2010;5:606\u201311.","journal-title":"J Thorac Oncol"},{"key":"2387_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/ejcts\/ezv168","volume":"48","author":"GL Hickey","year":"2015","unstructured":"Hickey GL, Dunning J, Seifert B, Sodeck G, Carr MJ, Burger HU, et al. Statistical and data reporting guidelines for the European Journal of Cardio-Thoracic Surgery and the Interactive CardioVascular and Thoracic Surgery. Eur J Cardiothorac Surg. 2015;48:180\u201393.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2387_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc. 1958;53:457\u201381.","journal-title":"J Am Statist Assoc"},{"key":"2387_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.radonc.2009.08.003","volume":"95","author":"JP Grutters","year":"2010","unstructured":"Grutters JP, Kessels AG, Pijls-Johannesma M, De Ruysscher D, Joore MA, Lambin P. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol. 2010;95:32\u201340.","journal-title":"Radiother Oncol"},{"key":"2387_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/cancers13010112","volume":"13","author":"T Ono","year":"2020","unstructured":"Ono T, Yamamoto N, Nomoto A, Nakajima M, Isozaki Y, Kasuya G, et al. Long term results of single-fraction carbon-ion radiotherapy for non-small cell lung cancer. Cancers. 2020;13:112.","journal-title":"Cancers"},{"key":"2387_CR28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0003-4975(03)01511-X","volume":"77","author":"N Sawabata","year":"2004","unstructured":"Sawabata N, Ohta M, Matsumura A, Nakagawa K, Hirano H, Maeda H, et al. Thoracic Surgery Study Group of Osaka University. Optimal distance of malignant negative margin in excision of non-small cell lung cancer: a multicenter prospective study. Ann Thorac Surg. 2004;77:415\u201320.","journal-title":"Ann Thorac Surg"},{"issue":"1350\u20131357","key":"2387_CR29","first-page":"e11","volume":"160","author":"J Wu","year":"2020","unstructured":"Wu J, Bai HX, Chan L, Su C, Zhang PJ, Yang L, et al. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: a National Cancer Database study. J Thorac Cardiovasc Surg. 2020;160(1350\u20131357):e11.","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-023-02387-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T14:04:05Z","timestamp":1702908245000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-023-02387-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2387"],"URL":"https:\/\/doi.org\/10.1186\/s13014-023-02387-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2828998\/v1","asserted-by":"object"}]},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,18]]},"assertion":[{"value":"17 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the institutional ethical committees of both Chibaken Saiseikai Narashino Hospital (approval number: 2019-12) and Chiba University (Approval Number: 3350). This study complied with the protocol, the current version of the Declaration of Helsinki. The participants consented to the study and publication in an opt-out format.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Teruaki Mizobuchi and co-authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"201"}}